相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors
Yang Yang et al.
CELL DEATH & DISEASE (2019)
IL-6 Plasma Levels Correlate With Cerebral Perfusion Deficits and Infarct Sizes in Stroke Patients Without Associated Infections
Benjamin Hotter et al.
FRONTIERS IN NEUROLOGY (2019)
NLRP3 inflammasome as a potential treatment in ischemic stroke concomitant with diabetes
Pu Hong et al.
JOURNAL OF NEUROINFLAMMATION (2019)
Plasma interleukin 6 levels are associated with cardiac function after ST-elevation myocardial infarction
Hilde E. Groot et al.
CLINICAL RESEARCH IN CARDIOLOGY (2019)
The Multitasking Potential of Alarmins and Atypical Chemokines
Aphrodite Kapurniotu et al.
FRONTIERS IN MEDICINE (2019)
The Impact of Tumor Necrosis Factor-alpha and Interleukin-1 beta Levels and Polymorphisms on Long-Term Stroke Outcomes
Ju-Wan Kim et al.
EUROPEAN NEUROLOGY (2018)
Canadian stroke best practice recommendations: Secondary prevention of stroke, sixth edition practice guidelines, update 2017
Theodore Wein et al.
INTERNATIONAL JOURNAL OF STROKE (2018)
Predicting functional outcome of ischemic stroke patients in Romania based on plasma CRP, sTNFR-1, D-Dimers, NGAL and NSE measured using a biochip array
Adina Hutanu et al.
ACTA PHARMACOLOGICA SINICA (2018)
TNF-α-sensitive brain pericytes activate microglia by releasing IL-6 through cooperation between Iκβ-NFκB and JAK-STAT3 pathways
Junichi Matsumoto et al.
BRAIN RESEARCH (2018)
The solution structure of monomeric CCL5 in complex with a doubly sulfated N-terminal segment of CCR5
Meital Abayev et al.
FEBS JOURNAL (2018)
All roads lead to IL-6: A central hub of cardiometabolic signaling
Peter Libby et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2018)
SCIL-STROKE (Subcutaneous Interleukin-1 Receptor Antagonist in Ischemic Stroke) A Randomized Controlled Phase 2 Trial
Craig J. Smith et al.
STROKE (2018)
2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
William J. Powers et al.
STROKE (2018)
Layer- and Cell Type-Specific Modulation of Excitatory Neuronal Activity in the Neocortex
Gabriele Radnikow et al.
FRONTIERS IN NEUROANATOMY (2018)
Blocking CCL5-CXCL4 heteromerization preserves heart function after myocardial infarction by attenuating leukocyte recruitment and NETosis
Tanja Vajen et al.
SCIENTIFIC REPORTS (2018)
TNF-α (Tumor Necrosis Factor-): A Paradox in Thrombosis
Prakash Saha et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2018)
Mechanisms of Regulation of the Chemokine-Receptor Network
Martin J. Stone et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Postischemic Inflammation in Acute Stroke
Simone Vidale et al.
JOURNAL OF CLINICAL NEUROLOGY (2017)
C-C Chemokine Receptor Type 5 (CCR5)-Mediated Docking of Transferred Tregs Protects Against Early Blood-Brain Barrier Disruption After Stroke
Peiying Li et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2017)
Anti-Inflammatory Targets for the Treatment of Reperfusion Injury in Stroke
Atsushi Mizuma et al.
FRONTIERS IN NEUROLOGY (2017)
Intra-cerebral cannabidiol infusion-induced neuroprotection is partly associated with the TNF-α/TNFR1/NF-κB pathway in transient focal cerebral ischaemia
Sepideh Khaksar et al.
BRAIN INJURY (2017)
Beneficial potential of intravenously administered IL-6 in improving outcome after murine experimental stroke
Mads Hjortdal Gronhoj et al.
BRAIN BEHAVIOR AND IMMUNITY (2017)
Knockdown of C-C Chemokine Receptor 5 (CCR5) is Protective Against Cerebral Ischemia and Reperfusion Injury
Edna Constanza Gomez Victoria et al.
CURRENT NEUROVASCULAR RESEARCH (2017)
Global Burden of Stroke
Valery L. Feigin et al.
CIRCULATION RESEARCH (2017)
Neuroinflammatory biomarkers: From stroke diagnosis and prognosis to therapy
Alba Simats et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2016)
Interleukin-6 Receptor Polymorphisms Contribute to the Neurological Status of Korean Patients with Ischemic Stroke
Dong Hwan Kim et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2016)
Infarction Size, Interleukin-6, and Their Interaction Are Predictors of Short-Term Stroke Outcome in Young Egyptian Adults
Rasha M. Fahmi et al.
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2016)
Blood/Brain Biomarkers of Inflammation After Stroke and Their Association With Outcome: From C-Reactive Protein to Damage-Associated Molecular Patterns
Alejandro Bustamante et al.
NEUROTHERAPEUTICS (2016)
Inflammatory Markers and Outcomes After Lacunar Stroke Levels of Inflammatory Markers in Treatment of Stroke Study
Amelia K. Boehme et al.
STROKE (2016)
MKEY, a Peptide Inhibitor of CXCL4-CCL5 Heterodimer Formation, Protects Against Stroke in Mice
Yifang Fan et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2016)
Infarction Size, Interleukin-6, and Their Interaction Are Predictors of Short-Term Stroke Outcome in Young Egyptian Adults
Rasha M. Fahmi et al.
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2016)
PPARγ and IL-6-174G>C gene variants in Croatian patients with ischemic stroke
A. Bazina et al.
GENE (2015)
Rapid mitochondrial dysfunction mediates TNF-alpha-induced neurotoxicity
Danielle N. Doll et al.
JOURNAL OF NEUROCHEMISTRY (2015)
Inflammatory and metabolic markers and short-time outcome in patients with acute ischemic stroke in relation to TOAST subtypes
Marcio Francisco Lehmann et al.
METABOLIC BRAIN DISEASE (2015)
Pharmacological induction of CCL5 in vivo prevents gp120-mediated neuronal injury
Lee A. Campbell et al.
NEUROPHARMACOLOGY (2015)
INHIBITION OF INTERLEUKIN-6 ABOLISHES THE PROMOTING EFFECTS OF PAIR HOUSING ON POST-STROKE NEUROGENESIS
C. Meng et al.
NEUROSCIENCE (2015)
Small heterodimer partner interacts with NLRP3 and negatively regulates activation of the NLRP3 inflammasome
Chul-Su Yang et al.
NATURE COMMUNICATIONS (2015)
Rational modulation of the innate immune system for neuroprotection in ischemic stroke
Diana Amantea et al.
FRONTIERS IN NEUROSCIENCE (2015)
Soluble or soluble/membrane TNF-α inhibitors protect the brain from focal ischemic injury in rats
C. A. Arango-Davila et al.
INTERNATIONAL JOURNAL OF NEUROSCIENCE (2015)
Targeting the NLRP3 inflammasome in chronic inflammatory diseases: current perspectives
Ema Ozaki et al.
JOURNAL OF INFLAMMATION RESEARCH (2015)
PACAP27 is Protective Against Tat-Induced Neurotoxicity
Summer J. Rozzi et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2014)
Prognostic value of blood interleukin-6 in the prediction of functional outcome after stroke: A systematic review and meta-analysis
Alejandro Bustamante et al.
JOURNAL OF NEUROIMMUNOLOGY (2014)
Biochemical and inflammatory biomarkers in ischemic stroke: translational study between humans and two experimental rat models
Patricia Martinez-Sanchez et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2014)
Factors Influencing the Decline in Stroke Mortality A Statement From the American Heart Association/American Stroke Association
Daniel T. Lackland et al.
STROKE (2014)
RANTES has a potential to play a neuroprotective role in an autocrine/paracrine manner after ischemic stroke
Himiko Tokami et al.
BRAIN RESEARCH (2013)
Neuron - glia crosstalk in health and disease: fractalkine and CX3CR1 take centre stage
GK Sheridan et al.
OPEN BIOLOGY (2013)
CC Chemokine Receptors and Chronic Inflammation-Therapeutic Opportunities and Pharmacological Challenges
Gemma E. White et al.
PHARMACOLOGICAL REVIEWS (2013)
Time course of inflammatory cytokines in acute ischemic stroke patients and their relation to inter-alfa trypsin inhibitor heavy chain 4 and outcome
Amit R. Nayak et al.
ANNALS OF INDIAN ACADEMY OF NEUROLOGY (2012)
Essential role of interleukin-6 in post-stroke angiogenesis
Karen Gertz et al.
BRAIN (2012)
Towards the identification of blood biomarkers for acute stroke in humans: a comprehensive systematic review
Nazeeha Hasan et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2012)
Roles of Chemokine CXCL12 and its Receptors in Ischemic Stroke
Yongting Wang et al.
CURRENT DRUG TARGETS (2012)
Interleukin-1 receptor antagonist reverses stroke-associated peripheral immune suppression
Craig J. Smith et al.
CYTOKINE (2012)
Interleukin-6, a Major Cytokine in the Central Nervous System
Maria Erta et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2012)
Inflammatory cytokines in experimental and human stroke
Kate Lykke Lambertsen et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2012)
The immunology of acute stroke
Angel Chamorro et al.
NATURE REVIEWS NEUROLOGY (2012)
The Use of Blood Biomarkers to Predict Poor Outcome After Acute Transient Ischemic Attack or Ischemic Stroke
William Whiteley et al.
STROKE (2012)
Capture, crawl, cross: the T cell code to breach the blood-brain barriers
Britta Engelhardt et al.
TRENDS IN IMMUNOLOGY (2012)
Selected acute phase CSF factors in ischemic stroke: findings and prognostic value
Maia Beridze et al.
BMC NEUROLOGY (2011)
Chemokines and chemokine receptors: New actors in neuroendocrine regulations
William Rostene et al.
FRONTIERS IN NEUROENDOCRINOLOGY (2011)
Neurochemokines: a menage a trois providing new insights on the functions of chemokines in the central nervous system
William Rostene et al.
JOURNAL OF NEUROCHEMISTRY (2011)
Serum levels of cytokines and C-reactive protein in acute ischemic stroke patients, and their relationship to stroke lateralization, type, and infarct volume
Heidi Ormstad et al.
JOURNAL OF NEUROLOGY (2011)
CX3CL1 Is Neuroprotective in Permanent Focal Cerebral Ischemia in Rodents
Raffaela Cipriani et al.
JOURNAL OF NEUROSCIENCE (2011)
The immunology of stroke: from mechanisms to translation
Costantino Iadecola et al.
NATURE MEDICINE (2011)
Systemic chemokine levels, coronary heart disease, and ischemic stroke events The PRIME Study
F. Canoui-Poitrine et al.
NEUROLOGY (2011)
Association of Circulating Inflammatory Markers With Recurrent Vascular Events After Stroke A Prospective Cohort Study
William Whiteley et al.
STROKE (2011)
CC and CXC chemokines are pivotal mediators of cerebral injury in ischaemic stroke
Marisol Mirabelli-Badenier et al.
THROMBOSIS AND HAEMOSTASIS (2011)
Metalloproteinase and stroke infarct size: role for anti-inflammatory treatment?
Anna Morancho et al.
INNATE INFLAMMATION AND STROKE (2010)
Brain dendritic cells in ischemic stroke: Time course, activation state, and origin
Jennifer C. Felger et al.
BRAIN BEHAVIOR AND IMMUNITY (2010)
The Temporal Profile of Inflammatory Markers and Mediators in Blood after Acute Ischemic Stroke Differs Depending on Stroke Outcome
H. Worthmann et al.
CEREBROVASCULAR DISEASES (2010)
Age and sex dependent genetic effects of neuropeptide Y promoter polymorphism on susceptibility to ischemic stroke in Koreans
No S. Kim et al.
CLINICA CHIMICA ACTA (2010)
Interleukin-6 as an early predictor for one-year survival following an ischaemic stroke/transient ischaemic attack
S. Shenhar-Tsarfaty et al.
INTERNATIONAL JOURNAL OF STROKE (2010)
Tumor Necrosis Factor-α (TNF-α) Regulates Shedding of TNF-α Receptor 1 by the Metalloprotease-Disintegrin ADAM8: Evidence for a Protease-Regulated Feedback Loop in Neuroprotection
Joerg W. Bartsch et al.
JOURNAL OF NEUROSCIENCE (2010)
The Science of Stroke: Mechanisms in Search of Treatments
Michael A. Moskowitz et al.
NEURON (2010)
Systemic and Intraplaque Mediators of Inflammation Are Increased in Patients Symptomatic for Ischemic Stroke
Fabrizio Montecucco et al.
STROKE (2010)
Molecular biomarkers in stroke diagnosis and prognosis
Matthew B. Maas et al.
BIOMARKERS IN MEDICINE (2009)
Ambivalent aspects of interleukin-6 in cerebral ischemia: inflammatory versus neurotrophic aspects
Shigeaki Suzuki et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2009)
Plasma levels of inflammatory and thrombotic/fibrinolytic markers in acute ischemic strokes: Relationship with TOAST subtype, outcome and infarct site
Antonino Tuttolomondo et al.
JOURNAL OF NEUROIMMUNOLOGY (2009)
Microglia Protect Neurons against Ischemia by Synthesis of Tumor Necrosis Factor
Kate Lykke Lambertsen et al.
JOURNAL OF NEUROSCIENCE (2009)
Inflammatory mechanisms in ischemic stroke: therapeutic approaches
Shaheen E. Lakhan et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2009)
Pivotal role of cerebral interleukin-17-producing γδT cells in the delayed phase of ischemic brain injury
Takashi Shichita et al.
NATURE MEDICINE (2009)
Immuno-inflammatory activation in acute cardio-embolic strokes in comparison with other subtypes of ischaemic stroke
Giuseppe Licata et al.
THROMBOSIS AND HAEMOSTASIS (2009)
Pro-inflammatory and anti-inflammatory cytokines in acute ischemic stroke and their relation to early neurological deficit and stroke outcome
Vanja Basic Kes et al.
CLINICAL BIOCHEMISTRY (2008)
MIP-1 and MCP-1 induce migration of human umbilical cord blood cells in models of stroke
Lixian Jiang et al.
CURRENT NEUROVASCULAR RESEARCH (2008)
Role of inflammatory markers in brain ischemia
Manuel Rodriguez-Yanez et al.
CURRENT OPINION IN NEUROLOGY (2008)
Plasma proinflammatory and anti-inflammatory cytokine and catecholamine concentrations as predictors of neurological outcome in acute stroke patients
Jun Oto et al.
JOURNAL OF ANESTHESIA (2008)
Role of CX3CR1 (fractalkine receptor) in brain damage and inflammation induced by focal cerebral ischemia in mouse
Adam Denes et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2008)
The impact of inflammation on the pathogenesis and prognosis of ischemic stroke
Taizen Nakase et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2008)
Blood cell-derived RANTES mediates cerebral microvascular dysfunction, inflammation, and tissue injury after focal ischemia-reperfusion
Satoshi Terao et al.
STROKE (2008)
Contribution of downregulation of L-type calcium currents to delayed neuronal death in rat hippocampus after global cerebral ischemia and reperfusion
Xiao-Ming Li et al.
JOURNAL OF NEUROSCIENCE (2007)
Clinical outcome following acute ischaemic stroke relates to both activation and autoregulatory inhibition of cytokine production
Hedley C. A. Emsley et al.
BMC NEUROLOGY (2007)
The role of inflammation in CNS injury and disease
SM Lucas et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
RANTES stimulates Ca2+ mobilization and inositol trisphosphate (IP3) formation in cells transfected with G protein-coupled receptor 75
A. Ignatov et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
Interleukin-6 biology is coordinated by membrane-bound and soluble receptors: role in inflammation and cancer
Stefan Rose-John et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2006)
Effects of the chemokine CCL2 on blood-brain barrier permeability during ischemia-reperfusion injury
Oliver B. Dimitrijevic et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2006)
NMDA receptor/L-VGCC-dependent expression and AMPA/KA receptor-dependent activation of c-Jun induced by cerebral ischemia in rat hippocampus
Quan-Guang Zhang et al.
NEUROSCIENCE LETTERS (2006)
Differential effects of chemokines on oligodendrocyte precursor proliferation and myelin formation in vitro
Linda Kadi et al.
JOURNAL OF NEUROIMMUNOLOGY (2006)
Expression of the inflammatory chemokines CCL5, CCL3 and CXCL10 in juvenile idiopathic arthritis, and demonstration of CCL5 production by an atypical subset of CD8+T cells
Daniel S. Pharoah et al.
ARTHRITIS RESEARCH & THERAPY (2006)
Role of chemokines in ischemic neuronal stress
M Minami et al.
NEUROMOLECULAR MEDICINE (2005)
Chemokines: multiple levels of leukocyte migration control
B Moser et al.
TRENDS IN IMMUNOLOGY (2004)
International Union of Pharmacology. XXX. Update on chemokine receptor nomenclature
PM Murphy
PHARMACOLOGICAL REVIEWS (2002)
Expression of fractalkine and its receptor, CX3CR1, in response to ischaemia-reperfusion brain injury in the rat
G Tarozzo et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2002)
Chemokines in pathology and medicine
M Baggiolini
JOURNAL OF INTERNAL MEDICINE (2001)
分享论文
